Allergic Rhinitis, Asthma, and Rhinosinusitis: Diseases of the Integrated Airway

por Meltzer, Eli O., Szwarcberg, Javier, Pill, Michael W.
Publicado 2004

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial(§)

por Gallant, Joel, Moyle, Graeme, Berenguer, Juan, Shalit, Peter, Cao, Huyen, Liu, Ya-Pei, Myers, Joel, Rosenblatt, Lisa, Yang, Lingfeng, Szwarcberg, Javier
Publicado 2017

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor

por Fisher, Martin, McDonald, Cheryl, Moyle, Graeme, Martorell, Claudia, Ramgopal, Moti, Laplante, Francois, Curley, Joanne, Graham, Hiba, Tran-Muchowski, Cecilia, Liu, Yapei, Rhee, Martin, Szwarcberg, Javier
Publicado 2014

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years

por Gazzard, Brian, Marie Girard, Pierre, Di Perri, Giovanni, Gallant, Joel, Towner, William, Rogatto, Felipe, Demorin, Jennifer, McColl, Damian, Liu, Hui, Rhee, Martin, Szwarcberg, Javier, Piontkowsky, David
Publicado 2014

Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adults

por Tashima, Karen, Crofoot, Gordon, Tomaka, Frank L, Kakuda, Thomas N, Brochot, Anne, Vanveggel, Simon, Opsomer, Magda, Garner, William, Margot, Nicolas, Custodio, Joseph M, Fordyce, Marshall W, Szwarcberg, Javier
Publicado 2014

Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial

por Tashima, Karen, Crofoot, Gordon, Tomaka, Frank L, Kakuda, Thomas N, Brochot, Anne, Van de Casteele, Tom, Opsomer, Magda, Garner, William, Margot, Nicolas, Custodio, Joseph M, Fordyce, Marshall W, Szwarcberg, Javier
Publicado 2014